SecBot SecBot

PURE

PURE BIOSCIENCE, INC.
OTC· Miscellaneous Chemical Products· Inc. DE· CIK 0001006028 Biotech & Drug Discovery
$0.0900 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.0900
Next earnings
Nov 3
in 7 days
1 year
+12.5%
from $0.0800 · Oct 27
30 days
+50.0%
from $0.0600
52-week range
$0.0400–0.1000
−10% from high · low Dec 31
Avg volume 20D
23.7K
Oct 6 spike 209.4K
Short interest
🔒 Subscribers only
Filing reports
4
analyzed by SecBot
SecBot read BEARISH 1 report · 90 days
Balance 1 bearish · 0 bullish oldest → newest, height = score
Avg score ·High conf. 1/1 ·Next Earnings date, Nov 3, 2026
Strongest BEARISH Pure Bioscience raised $555,000 in a private placement, issuing 10,183,486 shares at $0.0545 per share to…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

  • X Jul 31 Short interest jumps 100.2% to 7.7K
  • X Aug 14 Short interest jumps 30.5% to 10.1K
  • X Aug 31 Short interest jumps 52.0% to 15.3K

Signal stack

Where each data set points today.

  • TrendUPTREND

    23% above its 50-day average.

The Street

last action Dec 2012
Recent actions
DateFirmActionRating
Dec 13, 2012Zacks Investment Research
DOWNGRADE
DOWNGRADENeutral
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Upcoming
Nov 3, 2026
Earnings date
PURE Q4 2026 Earnings Scheduled — 2026-11-03
Recent
Jun 16, 2026
Earnings date
PURE Q3 2026 Earnings Scheduled — 2026-06-16
Mar 18, 2026
Earnings date
PURE Q2 2026 Earnings Scheduled — 2026-03-18

Earnings setup

Estimates
Nov 3
reports in 7 days
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
🔒 Subscribers only
shares short
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Oct 20, 2026 SEC
Pure Bioscience raised $555,000 in a private placement, issuing 10,183,486 shares at $0.0545 per share to director Tom…
8-K — Impact 5/10
Jun 16, 2026 Earnings calendar
PURE Q3 2026 Earnings Scheduled — 2026-06-16
Jun 15, 2026 SEC
PURE Bioscience reported fiscal Q3 2026 revenue of $506,000 (+3% YoY) but net loss widened to $624,000 from $580,000 a…
8-K — Impact 4/10
May 5, 2026 SEC
Pure Bioscience raised $1.0 million via a private placement, issuing 18,131,096 shares at $0.0553 per share (20%…
8-K — Impact 5/10

SecBot reports

4 filings · 0 bullish · 2 bearish · 1 mixed · 1 neutral
All PURE filing & press-release reports (4)